RECRUITING

US National OCS Liver Perfusion (OLP) Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight. TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.

Official Title

US National OCS Liver Perfusion (OLP) Registry

Quick Facts

Study Start:2021-10-14
Study Completion:2031-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05940857

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Kelly Jork
CONTACT
978-494-3918
kjork@transmedics.com
Kausar Qidwai
CONTACT
kqidwai@transmedics.com

Principal Investigator

Ahmed Elbetanony, MD
STUDY_DIRECTOR
TransMedics

Study Locations (Sites)

University of Alabama
Birmingham, Alabama, 35294
United States
Mayo Clinic Hospital Arizona
Phoenix, Arizona, 85054
United States
University of California San Diego
La Jolla, California, 92037
United States
University of California San Francisco
San Francisco, California, 94143
United States
Mayo Clinic Hospital Florida
Jacksonville, Florida, 32224
United States
Emory University Hospital
Atlanta, Georgia, 30322
United States
University of Kentucky Medical Center
Lexington, Kentucky, 40536
United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
United States
Lahey Clinic Medical Center
Burlington, Massachusetts, 01805
United States
University of Michigan Medical Center
Ann Arbor, Michigan, 48109
United States
Henry Ford Hospital
Detroit, Michigan, 48202
United States
Mayo Clinic Hospital Minnesota
Rochester, Minnesota, 55905
United States
SSM Health Saint Louis University Hospital
Saint Louis, Missouri, 63103
United States
University of Nebraska Medical Center
Omaha, Nebraska, 68198
United States
NY Presbyterian Hospital/Columbia Univ. Medical Center
New York, New York, 10032
United States
Carolinas Medical Center/Atrium Health
Charlotte, North Carolina, 28203
United States
Duke Medical Center
Durham, North Carolina, 27710
United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107
United States
UT Southwestern Medical Center
Dallas, Texas, 75390
United States
Houston Methodist
Houston, Texas, 77030
United States
University Hospital, University of Texas Health Science Center
San Antonio, Texas, 78229
United States
University of Utah Medical Center
Salt Lake City, Utah, 84112
United States

Collaborators and Investigators

Sponsor: TransMedics

  • Ahmed Elbetanony, MD, STUDY_DIRECTOR, TransMedics

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-10-14
Study Completion Date2031-10

Study Record Updates

Study Start Date2021-10-14
Study Completion Date2031-10

Terms related to this study

Additional Relevant MeSH Terms

  • Liver Transplant